Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
290.40B | 232.26B | 176.95B | 140.80B | 126.95B | Gross Profit |
245.88B | 196.50B | 148.51B | 117.14B | 106.01B | EBIT |
128.34B | 102.57B | 74.81B | 58.64B | 54.13B | EBITDA |
137.38B | 113.33B | 76.41B | 64.83B | 58.56B | Net Income Common Stockholders |
100.99B | 83.68B | 55.52B | 47.76B | 42.14B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
26.31B | 30.23B | 23.57B | 17.48B | 12.76B | Total Assets |
465.80B | 314.49B | 241.26B | 194.51B | 144.92B | Total Debt |
102.79B | 27.01B | 25.78B | 26.64B | 10.36B | Net Debt |
87.13B | 12.61B | 13.13B | 15.93B | -2.40B | Total Liabilities |
322.31B | 207.93B | 157.77B | 123.76B | 81.60B | Stockholders Equity |
143.49B | 106.56B | 83.49B | 70.75B | 63.33B |
Cash Flow | Free Cash Flow | |||
69.66B | 70.01B | 64.13B | 47.62B | 29.87B | Operating Cash Flow |
120.97B | 108.91B | 78.89B | 55.00B | 51.95B | Investing Cash Flow |
-128.90B | -43.89B | -24.92B | -31.61B | -22.44B | Financing Cash Flow |
8.73B | -63.16B | -51.80B | -25.49B | -32.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $284.58B | 19.68 | 82.03% | 1.71% | 24.91% | 21.42% | |
76 Outperform | $209.31B | 12.11 | 40.81% | 3.80% | 4.26% | ― | |
76 Outperform | $221.23B | 28.89 | 19.81% | 2.10% | 15.48% | 22.70% | |
72 Outperform | $694.32B | 62.53 | 77.73% | 0.66% | 36.38% | ― | |
71 Outperform | $125.03B | 21.43 | 7.34% | 2.67% | -4.57% | 2.96% | |
63 Neutral | $351.09B | 84.43 | 61.94% | 3.21% | 5.45% | ― | |
52 Neutral | $5.35B | 3.96 | -42.60% | 2.86% | 17.58% | 1.27% |